Similarly, in breast cancer high MRE11 expression was associated with a more malignant behavior of the disease, lymph node metastasis, and higher recurrence rates after radiotherapy and chemotherapy [51], whereas low DKC1 expression and activity were related to a better prognosis [18]. The gene discussed is MRE11; the disease is metastatic malignant neoplasm in the lymph nodes.